These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 26069883)

  • 1. TBL1XR1 in physiological and pathological states.
    Li JY; Daniels G; Wang J; Zhang X
    Am J Clin Exp Urol; 2015; 3(1):13-23. PubMed ID: 26069883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TBL1X: At the crossroads of transcriptional and posttranscriptional regulation.
    Pray BA; Youssef Y; Alinari L
    Exp Hematol; 2022 Dec; 116():18-25. PubMed ID: 36206873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of transducin β-like 1 X-linked receptor 1 (TBL1XR1) in thyroid hormone metabolism and action in mice.
    Hu Y; Falize K; van Trotsenburg ASP; Hennekam R; Fliers E; Bruinstroop E; Boelen A
    Eur Thyroid J; 2023 Oct; 12(5):. PubMed ID: 37458724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear receptor repression: regulatory mechanisms and physiological implications.
    Stewart MD; Wong J
    Prog Mol Biol Transl Sci; 2009; 87():235-59. PubMed ID: 20374706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Loss of TBL1XR1 disrupts glucocorticoid receptor recruitment to chromatin and results in glucocorticoid resistance in a B-lymphoblastic leukemia model.
    Jones CL; Bhatla T; Blum R; Wang J; Paugh SW; Wen X; Bourgeois W; Bitterman DS; Raetz EA; Morrison DJ; Teachey DT; Evans WE; Garabedian MJ; Carroll WL
    J Biol Chem; 2014 Jul; 289(30):20502-15. PubMed ID: 24895125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A specific mutation in TBL1XR1 causes Pierpont syndrome.
    Heinen CA; Jongejan A; Watson PJ; Redeker B; Boelen A; Boudzovitch-Surovtseva O; Forzano F; Hordijk R; Kelley R; Olney AH; Pierpont ME; Schaefer GB; Stewart F; van Trotsenburg AS; Fliers E; Schwabe JW; Hennekam RC
    J Med Genet; 2016 May; 53(5):330-7. PubMed ID: 26769062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The complex genomic profile of ETV6-RUNX1 positive acute lymphoblastic leukemia highlights a recurrent deletion of TBL1XR1.
    Parker H; An Q; Barber K; Case M; Davies T; Konn Z; Stewart A; Wright S; Griffiths M; Ross FM; Moorman AV; Hall AG; Irving JA; Harrison CJ; Strefford JC
    Genes Chromosomes Cancer; 2008 Dec; 47(12):1118-25. PubMed ID: 18767146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transducin (β)-like 1 X-linked receptor 1 promotes gastric cancer progression via the ERK1/2 pathway.
    Zhou Q; Wang X; Yu Z; Wu X; Chen X; Li J; Zhu Z; Liu B; Su L
    Oncogene; 2017 Mar; 36(13):1873-1886. PubMed ID: 27694893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A corepressor/coactivator exchange complex required for transcriptional activation by nuclear receptors and other regulated transcription factors.
    Perissi V; Aggarwal A; Glass CK; Rose DW; Rosenfeld MG
    Cell; 2004 Feb; 116(4):511-26. PubMed ID: 14980219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PPARα and NCOR/SMRT corepressor network in liver metabolic regulation.
    Kang Z; Fan R
    FASEB J; 2020 Jul; 34(7):8796-8809. PubMed ID: 32396271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nuclear receptor corepressor transcriptional checkpoint controlling activator protein 1-dependent gene networks required for macrophage activation.
    Ogawa S; Lozach J; Jepsen K; Sawka-Verhelle D; Perissi V; Sasik R; Rose DW; Johnson RS; Rosenfeld MG; Glass CK
    Proc Natl Acad Sci U S A; 2004 Oct; 101(40):14461-6. PubMed ID: 15452344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nuclear receptor corepressor complexes in cancer: mechanism, function and regulation.
    Wong MM; Guo C; Zhang J
    Am J Clin Exp Urol; 2014; 2(3):169-87. PubMed ID: 25374920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene silencing by chicken ovalbumin upstream promoter-transcription factor I (COUP-TFI) is mediated by transcriptional corepressors, nuclear receptor-corepressor (N-CoR) and silencing mediator for retinoic acid receptor and thyroid hormone receptor (SMRT).
    Shibata H; Nawaz Z; Tsai SY; O'Malley BW; Tsai MJ
    Mol Endocrinol; 1997 Jun; 11(6):714-24. PubMed ID: 9171235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear TBLR1 as an ER corepressor promotes cell proliferation, migration and invasion in breast and ovarian cancer.
    Wu X; Zhan Y; Li X; Wei J; Santiago L; Daniels G; Deng F; Zhong X; Chiriboga L; Basch R; Xiong S; Dong Y; Zhang X; Lee P
    Am J Cancer Res; 2016; 6(10):2351-2360. PubMed ID: 27822424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Equilibrium interactions of corepressors and coactivators with agonist and antagonist complexes of glucocorticoid receptors.
    Wang Q; Blackford JA; Song LN; Huang Y; Cho S; Simons SS
    Mol Endocrinol; 2004 Jun; 18(6):1376-95. PubMed ID: 15016838
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological Interactions Between Mutant Thyroid Hormone Receptors and Corepressors and Their Modulation by a Thyroid Hormone Analogue with Therapeutic Potential.
    Harrus D; Déméné H; Vasquez E; Boulahtouf A; Germain P; Figueira AC; Privalsky ML; Bourguet W; le Maire A
    Thyroid; 2018 Dec; 28(12):1708-1722. PubMed ID: 30235988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Over-Expression of TBL1XR1 Indicates Poor Prognosis of Serous Epithelial Ovarian Cancer.
    Ma M; Yu N
    Tohoku J Exp Med; 2017 Mar; 241(3):239-247. PubMed ID: 28344213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TBLR1 regulates the expression of nuclear hormone receptor co-repressors.
    Zhang XM; Chang Q; Zeng L; Gu J; Brown S; Basch RS
    BMC Cell Biol; 2006 Aug; 7():31. PubMed ID: 16893456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transducin β-like 1, X-linked and nuclear receptor co-repressor cooperatively augment the ligand-independent stimulation of TRH and TSHβ gene promoters by thyroid hormone receptors.
    Takamizawa T; Satoh T; Miyamoto T; Nakajima Y; Ishizuka T; Tomaru T; Yoshino S; Katano-Toki A; Nishikido A; Sapkota S; Watanabe T; Okamura T; Ishida E; Horiguchi K; Matsumoto S; Ishii S; Ozawa A; Shibusawa N; Okada S; Yamada M
    Endocr J; 2018 Aug; 65(8):805-813. PubMed ID: 29794369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two decades of a protooncogene TBL1XR1: from a transcription modulator to cancer therapeutic target.
    Du R; Li K; Guo K; Chen Z; Zhao X; Han L; Bian H
    Front Oncol; 2024; 14():1309687. PubMed ID: 38347836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.